Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$858M |
| 2 |
Costco
COST
|
+$557M |
| 3 |
UnitedHealth
UNH
|
+$551M |
| 4 |
Atlassian
TEAM
|
+$489M |
| 5 |
Northrop Grumman
NOC
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$579M |
| 2 |
TSMC
TSM
|
+$433M |
| 3 |
Airbnb
ABNB
|
+$426M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$341M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Consumer Discretionary | 23.3% |
| 3 | Healthcare | 16.47% |
| 4 | Financials | 9.42% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Nutrien
NTR
$32.1B
| $9.67M | 0.01% |
116,027
+436
| +0.4% | +$37.5K |
|
402
Cameco
CCJ
$41.1B
| $9.44M | 0.01% |
+355,972
| New | +$9.11M |
|
403
Azenta
AZTA
$1.47B
| $9.42M | 0.01% |
219,864
-2,048
| -0.9% | -$122K |
|
404
Bally's
BALY
$686M
| $9.36M | 0.01% |
473,515
-104,337
| -18% | -$2.39M |
|
405
Corteva
CTVA
$52.5B
| $9.21M | 0.01% |
161,112
+2,930
| +2% | +$171K |
|
406
Citi Trends
CTRN
$606M
| $8.68M | 0.01% |
559,578
+30,442
| +6% | +$714K |
|
407
Moelis & Co
MC
$5.14B
| $8.5M | 0.01% |
251,460
-19,432
| -7% | -$814K |
|
|
OSH
408
DELISTED
Oak Street Health, Inc.
OSH
| $8.48M | 0.01% |
+346,060
| New | +$9.15M |
|
409
General Mills
GIS
$19.2B
| $8.33M | 0.01% |
108,715
+69,203
| +175% | +$5.28M |
|
|
DCP
410
DELISTED
DCP Midstream, LP
DCP
| $8.25M | 0.01% |
219,593
-1,030,538
| -82% | -$36.1M |
|
411
New Fortress Energy
NFE
$95.4M
| $8.07M | 0.01% |
184,547
+47,516
| +35% | +$2.38M |
|
412
Kinder Morgan
KMI
$69.3B
| $7.84M | 0.01% |
471,063
| – | – |
|
413
Sea Limited
SE
$70.4B
| $7.43M | 0.01% |
132,625
-3,225
| -2% | -$224K |
|
414
Enviri
NVRI
$647M
| $7.38M | 0.01% |
1,974,630
-44,416
| -2% | -$246K |
|
415
Madrigal Pharmaceuticals
MDGL
$11.9B
| $7.38M | 0.01% |
113,500
-68,946
| -38% | -$4.79M |
|
416
Rogers Communications
RCI
$18.3B
| $7.11M | 0.01% |
184,548
-198,865
| -52% | -$8.8M |
|
417
California Resources
CRC
$4.56B
| $7.08M | 0.01% |
+184,243
| New | +$8.01M |
|
418
Cogent Communications
CCOI
$644M
| $7.05M | 0.01% |
+135,188
| New | +$7.79M |
|
419
Steel Dynamics
STLD
$38.1B
| $6.96M | 0.01% |
98,102
-40,422
| -29% | -$3.06M |
|
|
APTV.PRA
420
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
| $6.88M | 0.01% |
72,300
| – | – |
|
421
EOG Resources
EOG
$71.5B
| $6.78M | 0.01% |
60,643
-45,790
| -43% | -$5.14M |
|
|
AGTI
422
DELISTED
Agiliti Inc
AGTI
| $6.71M | 0.01% |
+468,593
| New | +$8.68M |
|
|
DHR.PRB
423
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
| $6.57M | 0.01% |
4,872
| – | – |
|
424
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.88B
| $5.67M | 0.01% |
189,379
+55,526
| +41% | +$2.07M |
|
|
MAG
425
DELISTED
MAG Silver
MAG
| $5.66M | 0.01% |
452,974
+807
| +0.2% | +$9.99K |
|
Similar funds
Jennison Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Jennison Associates held 689 positions worth $101B, up 0.37% from $100B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q3 2022 filing shows 75 new, 294 increased, 218 reduced and 90 closed positions. Its largest new stake was T-Mobile US: 1,657,443 shares worth $222M. The largest sale was Nike, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2022 buy was T-Mobile US: 1,657,443 shares worth $222M.
- Jennison Associates added most to Vertex Pharmaceuticals in Q3 2022, an estimated $858M increase.
- Jennison Associates's biggest Q3 2022 reduction was Nike, cutting an estimated $579M.
- Jennison Associates fully exited Snap in Q3 2022, selling an estimated $197M.
- Jennison Associates's ten largest holdings make up 40% of its $101B portfolio in Q3 2022.
- Jennison Associates opened 75 new positions and closed 90 in Q3 2022.
- Jennison Associates's portfolio value rose 0.37% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.